통합검색
내가 찾은 검색어
'Bispecific Antibody' 에 대한 통합검색결과 28건입니다.
한빛사28건
-
Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions
- Nat. Rev. Clin. Oncol. Jan 06 2025, | https://doi.org/10.1038/s41571-024-00979-8
- 2025.01
-
Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma
- Ann. Oncol. Aug 13 2024, S0923-7534(24)03759-1 | https://doi.org/10.1016/j.annonc.2024.08.2239
- 2024.08
- 의약학
-
Strengthened binding affinity of bispecific antibody nanoplatforms improved the anti-tumor efficacy
- Chem. Eng. J. Available online 13 June 2024 | https://doi.org/10.1016/j.cej.2024.153128
- 2024.06
- 의약학
-
Anti-4-1BB×PD-L1 Bispecific Antibody Reinvigorates Tumor-Specific Exhausted CD8+ T Cells and Enhances the Efficacy of Anti-PD-1 Blockade
- Clin. Cancer Res. May 14 2024, | https://doi.org/10.1158/1078-0432.CCR-23-2864
- 2024.05
- 의약학
-
Comparison of CAR T-cell vs. bispecific antibody as third- or later-line large B-cell lymphoma therapy: A Meta-analysis
- Blood May 02 2024, blood.2023023419 | https://doi.org/10.1182/blood.2023023419
- 2024.05
- 의약학
-
Antibody-Conjugated Nanogel with Two Immune Checkpoint Inhibitors for Enhanced Cancer Immunotherapy
- Adv. Healthc. Mater. Apr 03 2024, | https://doi.org/10.1002/adhm.202400235
- 2024.04
- 바이오·의료융합
-
Asymmetric anti-CLL-1×CD3 bispecific antibody, ABL602 2+1, with attenuated CD3 affinity endows potent antitumor activity but limited cytokine release
- J. Immunother. Cancer Oct 2023, 11 (10) e007494 | https://doi.org/10.1136/jitc-2023-007494
- 2023.10
-
Amivantamab plus lazertinib in osimertinib-relapsed EGFR-mutant advanced non-small cell lung cancer: a phase 1 trial
- Nat. Med. 14 September 2023 | https://doi.org/10.1038/s41591-023-02554-7
- 2023.09
- 의약학
-
Novel bispecific human antibody platform specifically targeting a fully open spike conformation potently neutralizes multiple SARS-CoV-2 variants
- Antiviral Res. 2023 Mar 2;212:105576 | https://doi.org/10.1016/j.antiviral.2023.105576
- 2023.03
- 생명과학
-
Targeting tumor vasculature to improve antitumor activity of T cells armed ex vivo with T cell engaging bispecific antibody
- J. Immunother. Cancer 2023 Mar;11(3):e006680 | http://dx.doi.org/10.1136/jitc-2023-006680
- 2023.03
-
T-cell engaging poly(lactic-co-glycolic acid) nanoparticles as a modular platform to induce a potent cytotoxic immunogenic response against PD-L1 over
- Biomaterials Volume 291, December 2022, 121911 | https://doi.org/10.1016/j.biomaterials.2022.121911
- 2022.12
- 의약학
-
LAG-3xPD-L1 bispecific antibody potentiates antitumor responses of T cells through dendritic cell activation
- Mol. Ther. Available online 6 May 2022 | https://doi.org/10.1016/j.ymthe.2022.05.003
- 2022.05
- 의약학
-
Overcoming tumor heterogeneity by ex vivo arming of T cells using multiple bispecific antibodies
- J. Immunother. Cancer Online issue publication January 27, 2022 | http://dx.doi.org/10.1136/jitc-2021-003771
- 2022.01
-
In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy
- Sci. Adv. 21 Jan 2022, Vol 8, Issue 3 | DOI: 10.1126/sciadv.abj6901
- 2022.01
- 의약학
-
In vivo delivery of CRISPR-Cas9 using lipid nanoparticles enables antithrombin gene editing for sustainable hemophilia A and B therapy
- Sci. Adv. 21 Jan 2022, Vol 8, Issue 3 | DOI: 10.1126/sciadv.abj6901
- 2022.01
- 의약학
-
Novel potent anti-STEAP1 bispecific antibody to redirect T cells for cancer immunotherapy
- J. Immunother. Cancer Online issue publication September 08, 2021, 9:e003114 | doi: 10.1136/jitc-2021-003114
- 2021.09
-
Modulating tumor infiltrating myeloid cells to enhance bispecific antibody-driven T cell infiltration and anti-tumor response
- J. Hematol. Oncol. Published: 08 September 2021, 14, Article number: 142 | https://doi.org/10.1186/s13045-021-01156-5
- 2021.09
-
Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern
- Sci. Transl. Med. 14 Sep 2021 | DOI: 10.1126/scitranslmed.abj5413
- 2021.09
-
A PSMA-targeted bispecific antibody for prostate cancer driven by a small-molecule targeting ligand
- Sci. Adv. 11 Aug 2021: Vol. 7, no. 33, eabi8193 DOI: 10.1126/sciadv.abi8193
- 2021.08
- 바이오·의료융합
-
Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phas
- J. Clin. Oncol. 2021 Aug 2;JCO2100662. doi: 10.1200/JCO.21.00662.
- 2021.08
- 의약학
